Business Context and Reporting Period
Company: Glucotrack, Inc. (GCTK)
Filing Type: Form 8-K (Current Report)
Date of Report: December 17, 2024
Principal Executive Offices: Rutherford, NJ
Reporting Period: This filing reports a specific event occurring on December 17, 2024, rather than a financial reporting period.
Key Financial Metrics
This filing does not contain audited financial statements, revenue, profit, cash flow, or margin data. The primary financial metric disclosed relates to a potential capital raise:
- Maximum Offering Size: Up to $8.23 million in aggregate offering price.
- Security Type: Common Stock ($0.001 par value).
- Agent Commission: 3.0% of gross sales proceeds.
Material Changes
The material change reported is the entry into a definitive agreement on December 17, 2024:
- Agreement: At-the-Market (ATM) Sales Agreement with Dawson James Securities, Inc.
- Purpose: To issue and sell shares of common stock from time to time through an "at-the-market" equity offering program.
- Registration: Sales will be made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-282297), declared effective on October 3, 2024.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The filing does not provide specific financial guidance or operational outlook. The Company retains discretion to set parameters for sales, including the number of shares, timing, daily limitations, and minimum price thresholds. The Company is not obligated to sell any shares under the agreement.
Risks and Contingencies:
- Termination: The agreement may be terminated by either party upon prior notice or under certain circumstances, including a material adverse change in the Company.
- Market Conditions: Sales are subject to market conditions and the Company's discretion regarding pricing and volume.
- Legal Compliance: The report explicitly states it does not constitute an offer to sell securities in any state where such an offer would be unlawful prior to registration.
Investor Verification Checklist
- Verify the current market price of GCTK common stock to assess the potential dilution impact of an $8.23 million ATM offering.
- Review the full text of the Sales Agreement (Exhibit 1.1) for specific minimum price floors or daily volume caps not detailed in the summary.
- Confirm the Company's current cash position and liquidity needs to understand the urgency of utilizing this facility.
- Check subsequent filings to determine if and when shares have actually been sold under this agreement.